Abstract:Liposome is one of the most popular drug delivery system due to its structure similarity to cell, high biocompatibility, availability for loading various drugs(hydrophobic, hydrophilic or amphiphilic), etc. Since its first development in 1965, tremendous technical advances have been made in this field, resulting in tens of liposomal drugs applied in clinic. However, the liposomal technology is far from perfect. The defects of liposomal technology include low drug loading, insufficient tumor targeting, etc. This review focuses on some major advances in recent years in terms of drug loading, targeting delivery, controlled release, and imaging monitoring. Traditionally, the drug loading of liposome is conducted by a passive loading method, characterized with low drug loading capability, low encapsulating efficiency and high drug leaking. Although the development of pH gradient method makes some drug loaded at very high encapsulating efficiency, this method is only suitable for some ionizable drugs and the maximum drug loading capability is usually not higher than 10 wt%. The newly developed active loading procedure by ferrying hydrophobic drugs with ionizable cycolodextran makes active loading of hydrophobic drugs possible. The application of reverse-phase microemulsion enables some platinum-based drugs loaded in the liposome as a nanoprecipitate characterized with a remarkably high drug loading capability. Direct conjugating drugs onto the liposomal membrane is another promising method with high drug loading, high encapsulating efficiency and minimal drug leaking. Efficient target delivery of liposomes to tumors is critical in improving therapeutic efficacy, yet strategies involving ligand modification have been difficult to achieve in clinic. Many researches have shown that some physical methods including heat, laser, ultrasound and ionizing irradiation can not only significantly increase liposomal accumulation, but also control the drug release. This indicates that combining liposome-based therapy with some minimal-invasive physical therapy such as hyperthermia therapy, photodynamic therapy and radiation therapy would maximize the targeting ability of liposome and release the drug in a controlled manner. The unique lipid-encapsulated core-shell structure makes liposome a versatile platform for loading various drugs. The liposome can be used to co-encapsulate two or more drugs that target different pathways, thus making combination therapy possible. Compared to the single-drug therapy, the combination therapy offers several advantages including reduced dose, less drug resistance, low toxicity and improved efficacy. In addition to therapeutic agents, the liposome can also load some imaging agents, thus enabling liposome "visible". The development of "visible" liposome makes it possible to monitor in real time the behavior of liposomal drugs in vivo, which is impossible to do with conventional method. In conclusion, the liposome has witnessed many technical advances in recent years. However, to further optimize these advances and finally translate them into clinic to benefit patients, a lot more work still needs to do.

Methyl-Branched Liposomes as a Depot for Sustained Drug Delivery

Effect of Peg2000 on Drug Delivery Characterization from Solid Lipid Nanoparticles

A hyperbranched amphiphilic acetal polymer for pH-sensitive drug delivery

Stabilized Cell Membrane-Derived Vesicles by Lipid Anchoring for Enhanced Drug Delivery

Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.

Synthesis of α,ω-bis-Mercaptoacyl Poly(alkyl oxide)s and Development of Thioether Cross-Linked Liposome Scaffolds for Sustained Release of Drugs

Prolonged release from lipid nanoemulsions by modification of drug lipophilicity

Multifunctional Liposomal Drug Delivery Technology

High Drug Capacity of Nano-Levodopa-Liposomes: Preparation, In Vitro Release and Brain-Targeted Research

Tripolar Bolalipids as Key Components of Sustained-Release Drug Delivery Systems

Customizing biomimetic surface attributes of dendritic lipopeptide nanoplatforms for extended circulation

Ultra-Long-Term Delivery of Hydrophilic Drugs Using Injectable In Situ Cross-Linked Depots

Unlocking new dimensions in long-acting injectables using lipid mesophase-based beads

Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery

Polymeric micelles for oral drug delivery

Liposomal encapsulation of amoxicillin via microfluidics with subsequent investigation of the significance of PEGylated therapeutics

Preparation, Characterization and Pharmacokinetics of Amoitone B-loaded Long Circulating Nanostructured Lipid Carriers.

Adapting Liposomes for Oral Drug Delivery

Unravelling the interactions between small molecules and liposomal bilayers via molecular dynamics and thermodynamic modelling

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept

Advances in Lipid-Based Drug Delivery: Enhancing Efficiency for Hydrophobic Drugs